Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation

Detalles Bibliográficos
Autor principal: Kletzel, Morris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2013
Materias:
Scientific Comments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832307/
https://www.ncbi.nlm.nih.gov/pubmed/24255610
http://dx.doi.org/10.5581/1516-8484.20130104
_version_ 1782291658782539776
author Kletzel, Morris
author_facet Kletzel, Morris
author_sort Kletzel, Morris
collection PubMed
description
format Online
Article
Text
id pubmed-3832307
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Associação Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-38323072013-11-19 Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation Kletzel, Morris Rev Bras Hematol Hemoter Scientific Comments Associação Brasileira de Hematologia e Hemoterapia 2013 /pmc/articles/PMC3832307/ /pubmed/24255610 http://dx.doi.org/10.5581/1516-8484.20130104 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Scientific Comments
Kletzel, Morris
Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
title Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
title_full Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
title_fullStr Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
title_full_unstemmed Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
title_short Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
title_sort comment on: consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
topic Scientific Comments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832307/
https://www.ncbi.nlm.nih.gov/pubmed/24255610
http://dx.doi.org/10.5581/1516-8484.20130104
work_keys_str_mv AT kletzelmorris commentonconsolidationtreatmentforhighrisksolidtumorsinchildrenwithmyeloablativechemotherapyandautologoushematopoieticprogenitorstemcelltransplantation

Ejemplares similares